Employment as a Contingent Worker aligns well with individuals seeking career flexibility and non-traditional work arrangements, while also being motivated to produce exceptional results in prominent roles. Magnit Direct Source is a service provided by Magnit Global that connects top-tier talent directly to an industry-leading company. Daiichi Sankyo, Inc. and Magnit Global, in collaboration, offer flexible contingent assignments across diverse projects creating opportunities for engaging work.  As a Contingent Worker, you will not be employed Daiichi Sankyo, Inc. You will be employed by our Managed Service Provider, Magnit Global, which oversees the majority of our temporary contract recruitment.

Job Schedule:  Candidate can work 100% remote but must be able to work EST hours and participate in global meetings with Japan.

Job Summary: The Director, Translational Pathology will work across the Translational Science matrix to develop and implement pathology-based translational approaches to assessing PD and patient selection biomarkers for Oncology and Specialty Medicine programs. They will further serve as the scientific expert supporting digital pathology investigations and as a point of contact for developing and managing external partnerships in support of translational science and CDx programs. They will provide the expertise to create and integrate pathology datasets with broader multi-omic analyses to support hypothesis-driven translational research efforts with direct impact across the Development continuum. They will work in a highly collaborative environment. 

Responsibilities:

• Design and build internal digital pathology capabilities and support data generation for translational pathology evaluations across the portfolio. Develop and manage partnerships, largely focused on digital pathology, to support design and implementation of translational pathology plans.

• Lead development of the translational pathology strategic direction and support data generation for assigned assets, with a focus on the design and implementation of translational pathology plans.

• Provide expertise to the Daiichi Sankyo Global Research Development organization to ensure access to state-of-the-art thinking on appropriate translational pathology strategies, evaluating their scientific basis and clinical applicability, the validation status and any technical or statistical issues related to proposed business plans.

• Communicate with portfolio leaders in Clinical Development, Discovery, QCP, CDx, RA, MA or other relevant functions to ensure effective integration of translational pathology strategy into broader Translational/Program strategies.

Requirements:

• 5 or more years of post-doctoral and relevant industry experience with expertise in pathology-driven translational research, biomedical leadership and human translational research in clinical trials required
• Experience with digital/computational pathology technologies and translational research required
• Extensive experience in the discovery, characterization and utilization of innovative translational strategies across the continuum of preclinical and clinical stages preferred.
• Experience/knowledge in companion diagnostics device development preferred
• Demonstrated ability to define clear translational strategies anchored in disease biology and drug mechanism of action, aligned with clinical development required
• Deep knowledge in pathology-based and other biomarker technologies including immunohistochemistry (monoplex and multiplex), digital pathology, spatial analyses, NGS, immunoassay, proteomics including expertise in assay validation required
• MD or MD PhD with Anatomic Pathology board certification required. Training outside of US and equivalent education received outside of US is acceptable.

Hourly Pay Rate Range (dependent on location, experience, expectation)

The pay range that Magnit reasonably expects to pay for this position is: $ 133.93-$178.57/hr

Benefits: Medical, Dental, Vision, 401K (provided minimum eligibility hours are met)

#Remote